Prenetics (PRE)’ IM8 is excited to announce that its month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now underway aboard the International Space Station. Launched via SpaceX CRS-31 on November 4th at 9:29 pm EST, the mission aims to study accelerated aging and longevity by leveraging microgravity’s unique environment to accelerate aging processes at the cellular level. Microgravity offers a unique opportunity to study aging processes more rapidly than on Earth. The experiment focuses on autophagy, the process by which cells remove and recycle damaged components. Autophagy declines with age, contributing to cellular aging and associated health issues such as decreased immune function and chronic inflammation. By enhancing autophagy, it may be possible to mitigate these effects and improve overall healthspan.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PRE:
- Prenetics Reports Strong Growth with New Launches
- Prenetics reports Q3 EPS (84c) vs. (98c) last year
- Prenetics reiterates FY24 revenue target exceeding $33M
- Prenetics and David Beckham launch IM8 Health
- Tencent Invests in Prenetics’ Insighta for Cancer Detection
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
